The goal of this clinical trial is to investigate the impact of a 10-week moderate intensity interval walking training (MIIWT) program on kidney function markers in obese postmenopausal women. The main question it aims to answer is: Does MIIWT improve kidney function markers in this population? Researchers will compare MIIWT (designed to training group) to non-training intervention (designed to control group) to see if the training program works to improve kidney function markers. Participants in training group will: perform a 10-week MIIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
serum creatinine
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
blood urea nitrogen
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
serum uric acid
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
glomerular Filtration Rate
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
white blood cells count
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
neutrophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
lymphocytes
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
monocytes
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
eosinophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
basophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).